LT3310762T - Nauji 5-ht2 antagonistai - Google Patents
Nauji 5-ht2 antagonistaiInfo
- Publication number
- LT3310762T LT3310762T LTEP16731871.6T LT16731871T LT3310762T LT 3310762 T LT3310762 T LT 3310762T LT 16731871 T LT16731871 T LT 16731871T LT 3310762 T LT3310762 T LT 3310762T
- Authority
- LT
- Lithuania
- Prior art keywords
- antagonists
- novel
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/06—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/4155—1,2-Diazoles non condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
- A61K31/416—1,2-Diazoles condensed with carbocyclic ring systems, e.g. indazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/54—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Pyrrole Compounds (AREA)
- Indole Compounds (AREA)
- Steroid Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Pyridine Compounds (AREA)
- Pyrane Compounds (AREA)
- Quinoline Compounds (AREA)
- Furan Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP15173111.4A EP3109237A1 (en) | 2015-06-22 | 2015-06-22 | Novel 5-ht2 antagonists |
| PCT/EP2016/064446 WO2016207231A1 (en) | 2015-06-22 | 2016-06-22 | Novel 5-ht2 antagonists |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| LT3310762T true LT3310762T (lt) | 2020-10-12 |
Family
ID=53496439
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| LTEP16731871.6T LT3310762T (lt) | 2015-06-22 | 2016-06-22 | Nauji 5-ht2 antagonistai |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US10544103B2 (lt) |
| EP (2) | EP3109237A1 (lt) |
| JP (1) | JP6718886B2 (lt) |
| KR (1) | KR102610630B1 (lt) |
| CN (1) | CN107787321B (lt) |
| AU (1) | AU2016282325B2 (lt) |
| CA (1) | CA2988033C (lt) |
| CY (1) | CY1123880T1 (lt) |
| DK (1) | DK3310762T3 (lt) |
| ES (1) | ES2819499T3 (lt) |
| HK (1) | HK1247916A1 (lt) |
| HR (1) | HRP20201485T1 (lt) |
| HU (1) | HUE050667T2 (lt) |
| IL (1) | IL256496B (lt) |
| LT (1) | LT3310762T (lt) |
| MX (1) | MX2017016939A (lt) |
| PL (1) | PL3310762T3 (lt) |
| PT (1) | PT3310762T (lt) |
| RS (1) | RS61266B1 (lt) |
| RU (1) | RU2706229C2 (lt) |
| SI (1) | SI3310762T1 (lt) |
| WO (1) | WO2016207231A1 (lt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3753924A1 (en) | 2019-06-18 | 2020-12-23 | AnaMar AB | New tricyclic 5-ht2 antagonists |
| US20230111140A1 (en) * | 2019-08-29 | 2023-04-13 | University Of Cincinnati | Treatment of pain by targeting nr4a1 |
| WO2023196556A1 (en) * | 2022-04-07 | 2023-10-12 | Corbus Pharmaceuticals, Inc. | Cannabinoid receptor 1 antagonists/inverse agonists and uses thereof |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US641992A (en) * | 1898-03-31 | 1900-01-23 | Guillaume Arnaud Nussbaum | Steam-generator. |
| GB1223491A (en) * | 1967-10-13 | 1971-02-24 | American Home Prod | Guanidines |
| US4107326A (en) | 1977-05-06 | 1978-08-15 | American Cyanamid Company | Novel benzylideneaminoguanidines |
| SK287074B6 (sk) | 2000-03-23 | 2009-11-05 | Solvay Pharmaceuticals B. V. | 4,5-Dihydro-1H-pyrazolové deriváty, spôsoby ich prípravy, medziprodukty a ich použitie |
| BRPI0412554A (pt) | 2003-07-15 | 2006-09-19 | Bayer Healthcare Ag | pirazolinas como antagonistas par-1 para o tratamento de doenças distúrbios cardiovascular |
| DE102004061750A1 (de) | 2004-12-22 | 2006-07-06 | Bayer Healthcare Ag | Heteroaryl-substituierte Pyrazoline |
| DE102005014089A1 (de) | 2005-03-22 | 2006-09-28 | Schering Ag | Tetrahydronaphthalinderivate, Verfahren zu ihrer Herstellung und ihre Verwendung als Entzündungshemmer |
| RU2008137612A (ru) * | 2006-02-20 | 2010-03-27 | Астеллас Фарма Инк. (Jp) | Амидное производное или его соли |
| MX2008013285A (es) | 2006-04-27 | 2008-10-24 | Solvay Pharm Gmbh | Uso novedoso de moduladores del receptor canabinoide cbx como moduladores de los canales de potasio. |
| EP1882475A1 (en) * | 2006-07-26 | 2008-01-30 | Novartis AG | Method of treating disorders mediated by the fibroblast growth factor receptor |
| TWI428334B (zh) | 2006-09-22 | 2014-03-01 | Abbvie Bahamas Ltd | 作為５-ｈｔ6拮抗劑之磺醯基吡唑及磺醯基吡唑啉的甲脒衍生物 |
| AR070898A1 (es) * | 2008-03-18 | 2010-05-12 | Solvay Pharm Bv | Derivados de arilsulfonil pirazolin carboxamidina como antagonistas de 5-ht6 |
| EP2470270A1 (en) * | 2009-07-31 | 2012-07-04 | AnaMar AB | Compounds for treatment of inflammation |
| AU2011277426B2 (en) * | 2010-07-15 | 2015-04-23 | Sumitomo Pharma Co., Ltd. | Pyrazole compound |
| CN103827091B (zh) | 2011-07-01 | 2016-05-18 | 默克专利有限公司 | 二氢吡唑、其药物组合物及其治疗生育障碍的用途 |
-
2015
- 2015-06-22 EP EP15173111.4A patent/EP3109237A1/en not_active Withdrawn
-
2016
- 2016-06-22 HU HUE16731871A patent/HUE050667T2/hu unknown
- 2016-06-22 LT LTEP16731871.6T patent/LT3310762T/lt unknown
- 2016-06-22 AU AU2016282325A patent/AU2016282325B2/en active Active
- 2016-06-22 MX MX2017016939A patent/MX2017016939A/es unknown
- 2016-06-22 PT PT167318716T patent/PT3310762T/pt unknown
- 2016-06-22 JP JP2017561762A patent/JP6718886B2/ja active Active
- 2016-06-22 SI SI201630908T patent/SI3310762T1/sl unknown
- 2016-06-22 ES ES16731871T patent/ES2819499T3/es active Active
- 2016-06-22 WO PCT/EP2016/064446 patent/WO2016207231A1/en active Application Filing
- 2016-06-22 DK DK16731871.6T patent/DK3310762T3/da active
- 2016-06-22 CN CN201680036640.5A patent/CN107787321B/zh active Active
- 2016-06-22 US US15/737,125 patent/US10544103B2/en active Active
- 2016-06-22 RU RU2017140648A patent/RU2706229C2/ru active
- 2016-06-22 KR KR1020187001184A patent/KR102610630B1/ko active IP Right Grant
- 2016-06-22 PL PL16731871T patent/PL3310762T3/pl unknown
- 2016-06-22 RS RS20201293A patent/RS61266B1/sr unknown
- 2016-06-22 CA CA2988033A patent/CA2988033C/en active Active
- 2016-06-22 EP EP16731871.6A patent/EP3310762B1/en active Active
-
2017
- 2017-12-21 IL IL256496A patent/IL256496B/en active IP Right Grant
-
2018
- 2018-06-04 HK HK18107294.8A patent/HK1247916A1/zh unknown
-
2020
- 2020-09-17 HR HRP20201485TT patent/HRP20201485T1/hr unknown
- 2020-10-06 CY CY20201100935T patent/CY1123880T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1252163A1 (zh) | 受體 | |
| GB201514875D0 (en) | Receptor | |
| IL254476A0 (en) | Heterocyclylmethyl-thianouracil as adenosine-a2b receptor antagonists | |
| IL258737A (en) | Antagonists ep4 | |
| PL3259424T3 (pl) | Okucie wychylne | |
| SG11202002207QA (en) | Trpv2 antagonists | |
| AU361999S (en) | Ballustrade | |
| PL2985779T3 (pl) | Podstawa uchwytu bezpiecznikowego | |
| HK1247916A1 (zh) | 新型5-ht2拮抗劑 | |
| RS59627B1 (sr) | Kompozicija amina maskiranog mirisa | |
| PL2902575T3 (pl) | System okuciowy | |
| GB2540162B (en) | Tracers | |
| GB201707862D0 (en) | Tracers | |
| GB2530305B (en) | Tracers | |
| GB201418365D0 (en) | Tracers | |
| GB201409664D0 (en) | Tracers | |
| ZA201807767B (en) | Angiotensin-1-receptor antagonists | |
| PT3464324T (pt) | Antagonistas de recetores da angiotensina-1 | |
| GB2532617B (en) | Making diodes | |
| GB201508463D0 (en) | Minifig art | |
| GB201509453D0 (en) | Tracers | |
| AU2015165V (en) | PWBC12 Chamelaucium uncinatum | |
| AU362754S (en) | Playsuit | |
| AU2015211V (en) | SGIBL01-0 Scabiosa columbaria | |
| AU2015212V (en) | SGIPU2-0 Scabiosa columbaria |